Correction to: Lemborexant in insomnia disorder: a profile of its use
- PDF / 589,931 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 21 Downloads / 162 Views
CORRECTION
Correction to: Lemborexant in insomnia disorder: a profile of its use Hannah A. Blair1
© Springer Nature Switzerland AG 2020
Corrections to: Drugs & Therapy Perspectives (2020) 36:427–434 https://doi.org/10.1007/s40267-020-00771-5 The author has alerted us to the following errors, and the following corrections should be noted: Page 431, ‘What is the tolerability profile of lemborexant?’ section, paragraph 2, lines 2–6: the following sentence, which previously read: “Single and multiple doses of lemborexant 10 mg did not have any negative effects on the apnea-hypopoea index (a measure of OSA severity) or peripheral capillary oxygen saturation (a measure of respiratory function)”. should read: “Single and multiple doses of lemborexant 10 mg did not have any negative effects on the apnea-hypopnea index (a measure of OSA severity) or peripheral capillary oxygen saturation (a measure of respiratory function)”. Page 433, reference list: Reference 12, which previously read: 12. Beuckmann CT, Ueno T, Nakagawa M, et al. Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation. Sleep. 2019;42(6).
The original article can be found online at https://doi.org/10.1007/ s40267-020-00771-5. * Hannah A. Blair [email protected] 1
Springer Nature, Private Bag 65901, Mairangi Bay, Auckland 0754, New Zealand
should read: 12. Beuckmann CT, Ueno T, Nakagawa M, et al. Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation. Sleep. 2019;42(6):zsz076. Page 433, reference list: Reference 13, which previously read: 13. Mahoney CE, Mochizuki T, Scammell TE. Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice. Sleep. 2019;43(6). should read: 13. Mahoney CE, Mochizuki T, Scammell TE. Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice. Sleep. 2019;43(6):zsz302. Page 434, reference list: Reference 16, which previously read: 16. Moline M, et al. Effect of lemborexant compared with placebo and zolpidem extended release on sleep architecture in older adults with insomnia disorder [abstract]. Sleep Med. 2019;64(Suppl 1):s437. should read: 16. Moline M, Pinner K, Cheng J, et al. Effect of lemborexant compared with placebo and zolpidem extended release on sleep architecture in older adults with insomnia disorder [abstract]. Sleep Med. 2019;64(Suppl 1):s437. Page 434, reference list: Reference 29, which previously read: 29. Vermeeren A, Jongen S, Murphy P, et al. On-theroad driving performance the morning after bedtime Vol.:(0123456789)
administration of lemborexant in healthy adult and elderly volunteers. Sleep. 2019;42(4).
administration of lemborexant in healthy adult and elderly volunteers. Sleep. 2019;42(4):zsy260.
should read:
The original article has been updated.
29. Vermeeren A, Jongen S, Murphy P, et al. On-theroad driving performance the morning after bedtime
Data Loading...
